ArticleEClinicalMedicine2022

Efficacy and safety of glibenclamide therapy after intracerebral haemorrhage (GATE-ICH): A multicentre, prospective, randomised, controlled, open-label, blinded-endpoint, phase 2 clinical trial.

Jingjing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.